FRANCE 24: The malaria business: Big pharma vs natural medicine
“A medicinal plant called Artemisia annua (or sweet wormwood) has been used in China to treat malaria for 2,000 years and is still grown by farmers in Africa. But it’s not approved by the World Health Organization and remains banned in a number of countries, including France. Malaria claims almost half a million lives each year and Africa is worst affected. In recent years, the mosquitoes that spread the disease have become increasingly resistant to insecticide. FRANCE 24 brings you an in-depth investigation into the debate between those for and against this natural anti-malaria remedy, which appears as a threat to large pharmaceutical laboratories…” (Crutzen, 1/11).

PBS NewsHour: Fighting malaria in the remote reaches of Cambodia
“Malaria causes nearly half a million deaths worldwide every year. Ninety percent of them are in sub-Saharan Africa, where poor infrastructure limits delivery of drugs. But now there is worry that those drugs are losing effectiveness as disease strains become resistant. Special correspondent Fred de Sam Lazaro reports from Cambodia, where scientists are researching and tracking new outbreaks…” (de Sam Lazaro, 1/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.